2nd Quarter - Amendment

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Firm
Client
Income
—
Expenses
$1,920,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 21, 2008 $1,920,000 Replaced
2nd Quarter - Amendment (this page) Aug 19, 2009 $1,920,000 Yes

What was lobbied

21 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Outpatient Prospective Payment Service S. 3101: Medicare Improvements for Patients and Providers Act of 2008 Medicaid Rebates H.R. 1424 H.R. 6331 H.R. 3162 H.R. 1367 S.3101 Medicaid/Medicare Packages Dual Proportionality Medicaid Rebates in Hospital Outpatient Setting CMS AMP Regulations Access to Drug Pricing Data H.R. 5683

LobbyistCovered position, as disclosed
SUSIE AHN —
MELISSA BOWIE Chief Heath Counsel, Senate HELP, Subcommittee
BRENT ALAN DELMONTE —
SANDRA DENNIS —
TOM DILENGE —
JEANNE HAGGERTY Policy Advisor, Congressman Joe Barton
ELI JOSEPH —
JOHN SIRACUSA —
JOHN MACK TAYLOR —

Contacted: Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Treasury, Dept of; Congressional Budget Office (CBO); Small Business Administration (SBA); Food & Drug Administration (FDA); Securities & Exchange Commission (SEC); White House Office; State, Dept of (DOS); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Council of Economic Advisers (CEA); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Natl Economic Council (NEC); U.S. Trade Representative (USTR); U.S. Agency for International Development (USAID); Office of Science & Technology Policy (OSTP); SENATE; Agriculture, Dept of (USDA)

Bills named: H.R. 1367 (110th), H.R. 6331 (110th), S. 3101 (110th), H.R. 1424 (110th), H.R. 5683 (110th), H.R. 3162 (110th)

Food Industry (safety, labeling, etc.) FOO

Adventitious Presence (Low Level Presence) U.S. Government Policy Position for Codex Guidelines on Adventitious Presence Korea Trade Negotiations EU Trade Meetings Genetically Engineered (GE) Animals U.S. Government Policy Position for Codex Guidelines on Food Safety Risk Assessment for rDNA Animals FDA and USDA Draft Regulation of GE Animals H. R. 6432 Livestock Cloning/Product Labeling FDA Risk Assessment on Cloning USDA Marketing and Regulatory Programs, Cloning Transition Period USDA Economic Report on Impact of Cloning on US Agriculture and Food Production USDA National Organic Program, Advance Notice of Proposed Rulemaking Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 H.R. 3161 S. 1859 H.R. 992 S. 414 H.R. 1396 S. 536 H.R. 4855 H.R. 2419 S.2663 Funding for Food Safety at the Food and Drug Administration Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642)

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
PATRICK BRAERTON CARROLL Legislative Assistant, Congressman LaHood
BRENT ALAN DELMONTE —
BARBARA GLENN —
BILL A OLSON Legislative Assistant, Rep. John Shimkus

Contacted: Patent & Trademark Office (PTO); Office of Science & Technology Policy (OSTP); Commerce, Dept of (DOC); U.S. Agency for International Development (USAID); Natl Economic Council (NEC); Treasury, Dept of; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); State, Dept of (DOS); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); SENATE; Council of Economic Advisers (CEA); Securities & Exchange Commission (SEC); Centers For Medicare and Medicaid Services (CMS); White House Office; Small Business Administration (SBA); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS)

Bills named: H.R. 6432 (110th), H.R. 2642 (110th), S. 536 (110th), S. 414 (110th), S. 2663 (110th), H.R. 2419 (110th), H.R. 1396 (110th), H.R. 3161 (110th), H.R. 4855 (110th), S. 1859 (110th), H.R. 992 (110th)

Science/Technology SCI

Stem Cell Research Small Business Innovation and Research Program (SBIR) H.R. 5819: SBIR Reauthorization Act R&D Tax Credit H.R. 6049 Election of R&D/AMT Tax Credits in Lieu of Bonus Depreciation H.R. 3221 Technology Transfer Policies Technology Innovation Program (TIP) Proposed Rules by National Institutes for Standards & Technology Funding --Commerce, Justice, Science, and Related Agencies Appropriations Act for FY 2009

LobbyistCovered position, as disclosed
TRICIA BROOKS —
PATRICK BRAERTON CARROLL Legislative Assistant, Congressman LaHood
BRENT ALAN DELMONTE —
TOM DILENGE —
ALAN EISENBERG —
ELIZABETH CARTIER ESHAM —
ELI JOSEPH —
SHELLY MUI-LIPNIK —
PAUL POTEET —
TOOSHAR SWAIN New Legislative Correspondent, Senator Rick Santorum

Contacted: Congressional Budget Office (CBO); U.S. Agency for International Development (USAID); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); SENATE; Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); White House Office; Patent & Trademark Office (PTO); Treasury, Dept of; State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Small Business Administration (SBA); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Council of Economic Advisers (CEA); Natl Economic Council (NEC); Environmental Protection Agency (EPA); Securities & Exchange Commission (SEC); Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 6049 (110th), H.R. 5819 (110th), H.R. 3221 (110th)

Civil Rights/Civil Liberties CIV

Genetic Information Non-Discrimination Act S.358

LobbyistCovered position, as disclosed
MELISSA BOWIE Chief Health Counsel, Senate, HELP, Subcommittee
BRENT ALAN DELMONTE —
ELI JOSEPH —

Contacted: Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); Commerce, Dept of (DOC); SENATE; Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); Food & Drug Administration (FDA); Small Business Administration (SBA); Centers For Medicare and Medicaid Services (CMS); Natl Economic Council (NEC); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; White House Office; Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Treasury, Dept of; U.S. Agency for International Development (USAID); Patent & Trademark Office (PTO); Council of Economic Advisers (CEA); U.S. Trade Representative (USTR)

Bills named: S. 358 (110th)

Trade (domestic/foreign) TRD

Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement China Biotechnology Trade Negotiations Mexico Biotechnology Trade Negotiations Russia Biotechnology Trade Negotiations Vietnam Biotechnology Negotiations France Trade Meetings Taiwan Biotechnology Negotiations EU Trade Negotiations Adventitious Presence (Low Level Presence) U.S. Government Policy Position for Codex Guidelines on Adventitious Presence Korea Trade Negotiations EU Trade Meetings World Trade Organization on EU Biotech Approvals Review of EU Biotechnology Negotiations CBD TRIPS Amendment Patent Disclosure Requirements Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations Policies Impacting Global Trade of Ag-Biotech Products U.S. Government Positions International Market Access for U.S. Healthcare Products Healthcare Sector Advocacy/Free Trade Agreements Alliance for Healthcare Competitiveness Drug Importation Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009 Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Intellectual Property Provisions in U.S. Trade Agreements Korean Trade Agreement

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
PATRICK BRAERTON CARROLL Legislative Assistant, Congressman LaHood
SEAN DARRAGH —
BRENT ALAN DELMONTE —
TOM DILENGE —
LILA FEISEE —
KELLY LAI —
SARAH LUKIE —
PAUL POTEET —
JOHN MACK TAYLOR —

Contacted: Treasury, Dept of; Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Small Business Administration (SBA); Natl Economic Council (NEC); SENATE; Congressional Budget Office (CBO); U.S. Agency for International Development (USAID); Centers For Disease Control & Prevention (CDC); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); White House Office; Office of Science & Technology Policy (OSTP); Patent & Trademark Office (PTO); Agriculture, Dept of (USDA); Commerce, Dept of (DOC); State, Dept of (DOS); Council of Economic Advisers (CEA)

Accounting ACC

Sarbanes-Oxley Reform Section 404 SEC and PCAOB Guidance on Auditing Standard (AS-5) S.3260: Financial Services and General Government Appropriations Act for FY 2009 International Financial Reporting Standards Upcoming SEC Proposed Rules Net Operating Loss Limitation Reform/Internal Revenue Code Section 382 H.R. 3264: American Sciences Competitiveness Act Election of R&D/AMT Tax Credits in Lieu of Bonus Depreciation H.R. 3221

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
ALAN EISENBERG —
SHELLY MUI-LIPNIK —
PAUL POTEET —
TOOSHAR SWAIN New Legislative Correspondent, Senator Rick Santorum

Contacted: Treasury, Dept of; Office of Science & Technology Policy (OSTP); Securities & Exchange Commission (SEC); Council of Economic Advisers (CEA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); Natl Institutes of Health (NIH); SENATE; Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); U.S. Agency for International Development (USAID); Natl Economic Council (NEC); Agriculture, Dept of (USDA); White House Office; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Small Business Administration (SBA); State, Dept of (DOS); Environmental Protection Agency (EPA)

Bills named: H.R. 3264 (110th), S. 3260 (110th), H.R. 3221 (110th)

Agriculture AGR

Plant Protection Act Amendments/Penalties H.R. 6124 Livestock Cloning/Product Labeling FDA Risk Assessment on Cloning USDA Marketing and Regulatory Programs, Cloning Transition Period USDA Economic Report on Impact of Cloning on US Agriculture and Food Production USDA National Organic Program, Advance Notice of Proposed Rulemaking Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 H.R. 3161 S. 1859 H.R. 992 S. 414 H.R. 1396 S. 536 H.R. 4855 H.R. 2419 S.2663 Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement China Biotechnology Trade Negotiations Mexico Biotechnology Trade Negotiations Russia Biotechnology Trade Negotiations Vietnam Biotechnology Negotiations France Trade Meetings Taiwan Biotechnology Negotiations EU Trade Negotiations EPA Regulation of Plant Incorporated Protectants Proposed Rule Adventitious Presence (Low Level Presence) U.S. Government Policy Position for Codex Guidelines on Adventitious Presence Korea Trade Negotiations EU Trade Meetings Farm Legislation H.R. 2419 & H.R. 6124 USDA Administrative Proposals Livestock Cloning/Product Labeling Plant Protection Act Amendments/Penalties World Trade Organization on EU Biotech Approvals Review of EU Biotechnology Negotiations Genetically Engineered (GE) Animals U.S. Government Policy Position for Codex Guidelines on Food Safety Risk Assessment for rDNA Animals FDA and USDA Draft Regulation of GE Animals H.R. 6432 Biotechnology Crop Stewardship Biotechnology Quality Management Stewardship Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings USDA/APHIS Agricultural Biotechnology Regulations USDA Rulemaking on 7 CFR 340 U.S. Policy on Sustainable Agriculture Standard American National Standards Institute (ANSI) Bio-based Products Tax Credits EU Tracebility and Labeling Regulations for Ag-Biotech U.S. Policy on Ag-Biotech Benefits for G-8 Meeting Policies Impacting Global Trade of Ag-Biotech Products U.S. Government Positions

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
MELISSA BOWIE Chief Health Counsel, Senate HELP, Subcomm
PATRICK BRAERTON CARROLL Legislative Assistant, Congressman LaHood
BRENT ALAN DELMONTE —
TOM DILENGE —
BRENT ERICKSON —
BARBARA GLENN —
JEANNE HAGGERTY Policy Advisor, Congressman Joe Barton
ELI JOSEPH —
SARAH LUKIE —
BILL A OLSON Legislative Assistant, Rep. John Shimkus
PAUL POTEET —

Contacted: Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); Small Business Administration (SBA); Treasury, Dept of; Natl Institutes of Health (NIH); SENATE; U.S. Agency for International Development (USAID); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); White House Office; Commerce, Dept of (DOC); Natl Economic Council (NEC); Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); Council of Economic Advisers (CEA); Office of Management & Budget (OMB)

Bills named: S. 1859 (110th), H.R. 6124 (110th), S. 2663 (110th), S. 536 (110th), H.R. 3161 (110th), S. 414 (110th), H.R. 4855 (110th), H.R. 6432 (110th), H.R. 1396 (110th), H.R. 992 (110th), H.R. 2419 (110th)

Taxation/Internal Revenue Code TAX

Biofuels Tax Credit H.R. 2419/H.R. 6124 Bio-based Products Tax Credits R&D Tax Credit H.R. 6049 Election of R&D/AMT Tax Credits in Lieu of Bonus Depreciation H.R. 3221 Net Operating Loss Limitation Reform/Internal Revenue Code Section 382 H.R. 3264: American Sciences Competitiveness Act Comprehensive Biotechnology Tax Incentives Legislation H.R. 3264 Taxation of Collaborative Agreements IRS Coordinated Issue Paper

LobbyistCovered position, as disclosed
MATT CARR —
BRENT ALAN DELMONTE —
AMY EHLERS —
BRENT ERICKSON —
ELIZABETH CARTIER ESHAM —
ELI JOSEPH —
PAUL POTEET —
TOOSHAR SWAIN New Legislative Correspondent, Senator Rick Santorum

Contacted: Natl Institutes of Health (NIH); Congressional Budget Office (CBO); Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); Agriculture, Dept of (USDA); Council of Economic Advisers (CEA); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); State, Dept of (DOS); Small Business Administration (SBA); SENATE; Commerce, Dept of (DOC); Natl Economic Council (NEC); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); Treasury, Dept of; Health & Human Services, Dept of (HHS); White House Office

Bills named: H.R. 3264 (110th), H.R. 6049 (110th), H.R. 2419 (110th), H.R. 6124 (110th), H.R. 3221 (110th)

Homeland Security HOM

Funding for Pandemic Influenza Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for Biomedical Advanced Research Development Authority (BARDA) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for Bioterrorism and Emergency Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642)

LobbyistCovered position, as disclosed
PATRICK BRAERTON CARROLL Legislative Assistant, Congressman LaHood
CHRISTOPHER COLWELL —
BRENT ALAN DELMONTE —
ELI JOSEPH —
JOHN MACK TAYLOR —

Contacted: Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Treasury, Dept of; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Congressional Budget Office (CBO); Natl Economic Council (NEC); U.S. Agency for International Development (USAID); Office of Science & Technology Policy (OSTP); Small Business Administration (SBA); White House Office; HOUSE OF REPRESENTATIVES; Council of Economic Advisers (CEA); SENATE; Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 2642 (110th)

Copyright/Patent/Trademark CPT

Patent Reform H.R. 1908 S. 1145 CBD TRIPS Amendment Patent Disclosure Requirements PTO Proposed Regulations Continuation Rules: FR 2005-P-066 Claims Rules: FR 2005-P-067 Information Disclosure Rules: 71-FR-38808 Biologic Deposit Rule: 73-FR-34 Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations Bayh-Dole Act Evaluation Intellectual Property Enforcement Gene Patenting Intellectual Property Provisions in U.S. Trade Agreements Korean Trade Agreement

LobbyistCovered position, as disclosed
SUSIE AHN —
MELISSA BOWIE Chief Health Counsel, Senate HELP, Subcommittee
TRICIA BROOKS —
SEAN DARRAGH —
BRENT ALAN DELMONTE —
TOM DILENGE —
LILA FEISEE —
JEANNE HAGGERTY Policy Advisor, Congressman Joe Barton
ELI JOSEPH —
KELLY LAI —
PAUL POTEET —
HANSJORG SAUER —
JOHN MACK TAYLOR —

Contacted: U.S. Agency for International Development (USAID); Patent & Trademark Office (PTO); Treasury, Dept of; Commerce, Dept of (DOC); Office of Management & Budget (OMB); White House Office; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); Small Business Administration (SBA); State, Dept of (DOS); Council of Economic Advisers (CEA); Congressional Budget Office (CBO); U.S. Trade Representative (USTR); SENATE; Natl Economic Council (NEC); Securities & Exchange Commission (SEC); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA)

Bills named: H.R. 1908 (110th), S. 1145 (110th)

Health Issues HCR

Drug Safety Implementation of Food & Drug Administration Amendments Act of 2007 Clinical Trial Registry and Results Databases Risk Management Plans Drug Safety Cont... Heparin Contamination Counterfeit Drugs FDA Globalization Act of 2008 H.R. 5839 Safeguarding America's Pharmaceuticals Act of 2008 H.R. 3610: The Food and Drug Import Safety Act of 2007 Stem Cell Research Medicaid Rebates H.R. 1424 H.R. 6331 H.R. 3162 H.R. 1367 S.3101 Medicaid/Medicare Packages Dual Proportionality Medicaid Rebates in Hospital Outpatient Setting CMS AMP Regulations Human Growth Hormone Regulation S.877 H.R. 4911 Follow-on Biologics H.R. 1038 H.R. 1956 H.R. 5629 S. 1695 FDA Regulatory Processes for First-Time Filers Funding for Biomedical Advanced Research & Development Authority (BARDA) Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Vaccine Financing National Vaccine Advisory Committee Draft Recommendations Vaccines for Children Program National Vaccine Advisory Committee Draft Recommendations Influenza Vaccine Supply and Immunization Recommendations Barriers and Incentives Related to Personalized Medicine Outpatient Prospective Patient Services S. 3101: Medicare Improvements for Patients and Providers Act of 2008 In Vitro Diagnostics Regulatory Oversight Comparative Effectiveness Program Initiatives H.R. 6331 S. 3101 Medicare/Medicaid Packages International Market Access for U.S. Healthcare Products Healthcare Sector Advocacy/Free Trade Agreements Alliance for Healthcare Competitiveness Funding for National Institutes of Health Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for Bioterrorism and Emergency Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for Pandemic Influenza Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for the Food and Drug Administration Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 (Human Drug, Biologics, Food Safety, Critical Path, Regan-Udall Foundation, Center for Veterinary Medicine) FY 2008 Supplemental Appropriations Bill (H.R. 2642) Access to Investigation Drugs for Seriously Ill Patents The Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (S.1956) Physician Payments Sunshine Act S.2029 Access to Drug Pricing Data H.R. 5683 Drug Importation Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009 Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 FDA Debarment H.R. 6378: The Strengthening of FDA Integrity Act Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations

LobbyistCovered position, as disclosed
SUSIE AHN —
MELISSA BOWIE Chief Health Counsel, Senate HELP, Subcommittee
TRICIA BROOKS —
EDWARD BUCKLEY —
PATRICK BRAERTON CARROLL Legislative Assistant, Congressman LaHood
CHRISTOPHER COLWELL —
SEAN DARRAGH —
BRENT ALAN DELMONTE —
SANDRA DENNIS —
ANDREW EMMETT —
ELIZABETH CARTIER ESHAM —
LILA FEISEE —
JEANNE HAGGERTY Policy Advisor, Congressman Joe Barton
ELI JOSEPH —
KELLY LAI —
KATHERINE MCCARTHY —
PAUL POTEET —
DARYL PRITCHARD New —
SARA RADCLIFFE —
JOHN SIRACUSA —
JOHN MACK TAYLOR —

Contacted: Centers For Disease Control & Prevention (CDC); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Congressional Budget Office (CBO); State, Dept of (DOS); Environmental Protection Agency (EPA); Securities & Exchange Commission (SEC); Council of Economic Advisers (CEA); Agriculture, Dept of (USDA); Office of Science & Technology Policy (OSTP); Commerce, Dept of (DOC); SENATE; Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Small Business Administration (SBA); Office of Management & Budget (OMB); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); Treasury, Dept of; White House Office; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1956 (110th), H.R. 1367 (110th), H.R. 2642 (110th), H.R. 6378 (110th), H.R. 1956 (110th), H.R. 6331 (110th), H.R. 5839 (110th), S. 877 (110th), S. 2029 (110th), H.R. 4911 (110th), S. 3101 (110th), H.R. 5629 (110th), H.R. 1038 (110th), H.R. 3610 (110th), H.R. 3162 (110th), H.R. 1424 (110th), S. 1695 (110th), H.R. 5683 (110th)

Medical/Disease Research/Clinical Labs MED

Funding for Bioterrorism and Emergency Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for National Institutes of Health Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for Biomedical Advanced Research Development Authority (BARDA) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for Pandemic Influenza Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for the Food and Drug Administration Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 (Human Drug, Biologics, Food Safety, Critical Path, Regan-Udall Foundation, Center for Veterinary Medicine) FY 2008 Supplemental Appropriations Bill (H.R. 2642) In Vitro Diagnostics Regulatory Oversight Comparative Effectiveness Program Initiatives H.R. 6331 S. 3101 Medicare/Medicaid Packages Stem Cell Research Barriers and Incentives Related to Personalized Medicine

LobbyistCovered position, as disclosed
SUSIE AHN —
MELISSA BOWIE Chief Health Counsel, Senate HELP, Subcommittee
TRICIA BROOKS —
PATRICK BRAERTON CARROLL Legislative Assistant, Congressman LaHood
CHRISTOPHER COLWELL —
BRENT ALAN DELMONTE —
SANDRA DENNIS —
TOM DILENGE —
JEANNE HAGGERTY Policy Advisor, Congressman Joe Barton
ELI JOSEPH —
DARYL PRITCHARD New —
SARA RADCLIFFE —
JOHN SIRACUSA —
JOHN MACK TAYLOR —

Contacted: Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Natl Economic Council (NEC); Securities & Exchange Commission (SEC); Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); Council of Economic Advisers (CEA); Patent & Trademark Office (PTO); Congressional Budget Office (CBO); U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); Treasury, Dept of; Small Business Administration (SBA); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Centers For Disease Control & Prevention (CDC); White House Office; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Environmental Protection Agency (EPA); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2642 (110th), S. 3101 (110th), H.R. 6331 (110th)

Law Enforcement/Crime/Criminal Justice LAW

Human Growth Hormone Regulation S.877 H.R. 4911

LobbyistCovered position, as disclosed
SUSIE AHN —
MELISSA BOWIE Chief Health Counsel, Senate, HELP, Subcommittee
BRENT ALAN DELMONTE —
SANDRA DENNIS —
TOM DILENGE —
JEANNE HAGGERTY Policy Advisor, Congressman Joe Barton
ELI JOSEPH —
SARA RADCLIFFE —
JOHN MACK TAYLOR —

Contacted: Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Natl Economic Council (NEC); Congressional Budget Office (CBO); Commerce, Dept of (DOC); Food & Drug Administration (FDA); Small Business Administration (SBA); Council of Economic Advisers (CEA); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Treasury, Dept of; State, Dept of (DOS); Environmental Protection Agency (EPA); U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); Securities & Exchange Commission (SEC); Office of Science & Technology Policy (OSTP); SENATE; Health & Human Services, Dept of (HHS); White House Office

Bills named: S. 877 (110th), H.R. 4911 (110th)

Small Business SMB

Small Business Innovation and Research Program (SBIR) H.R. 5819: SBIR Reauthorization Act Sarbanes-Oxley Reform Section 404 SEC and PCAOB Guidance on Auditing Standard (AS-5) S.3260: Financial Services and General Government Appropriations Act for FY 2009 FDA Regulatory Processes for First-Time Filers Election of R&D/AMT Tax Credits in Lieu of Bonus Depreciation H.R. 3221 Net Operating Loss Limitation Reform/Internal Revenue Code Section 382 H.R. 3264: American Sciences Competitiveness Act

LobbyistCovered position, as disclosed
SUSIE AHN —
MELISSA BOWIE Chief Health Counsel, Senate HELP, Subcommittee
TRICIA BROOKS —
BRENT ALAN DELMONTE —
TOM DILENGE —
ALAN EISENBERG —
ELIZABETH CARTIER ESHAM —
ELI JOSEPH —
SHELLY MUI-LIPNIK —
PAUL POTEET —
TOOSHAR SWAIN New Legislative Correspondent, Senator Rick Santorum

Contacted: State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); Commerce, Dept of (DOC); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); SENATE; Treasury, Dept of; Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Council of Economic Advisers (CEA); Office of Science & Technology Policy (OSTP); White House Office; Food & Drug Administration (FDA); Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Small Business Administration (SBA); Natl Institutes of Health (NIH); Natl Economic Council (NEC); U.S. Agency for International Development (USAID)

Bills named: S. 3260 (110th), H.R. 3264 (110th), H.R. 5819 (110th), H.R. 3221 (110th)

Budget/Appropriations BUD

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Funding for the Food and Drug Administration (Human Drug, Biologics, Food Safety, Critical Path, Regan-Udall Foundation, Center for Veterinary Medicine) Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 (Cont...) Funding for the USDA (Office of General Counsel, Biotechnology Regulatory Service (APHIS), Animal Care & Veterinary Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture Research Service, Biofuels (Rural Development)) Drug Importation Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Funding for National Institutes of Health Funding for Bioterrorism and Emergency Preparedness Funding for Pandemic Influenza Preparedness Funding for Biomedical Advanced Research & Development Authority (BARDA) Drug Importation Energy and Water Development and Related Agencies Appropriations Act for FY 2009 Funding for Biofuels S.3260: Financial Services and General Government Appropriations Act for FY 2009 Sarbanes Oxley - Section 404 Commerce, Justice, Science, and Related Agencies Appropriations Act for FY 2009 Funding for Technology Innovation Program (TIP) Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2009 Funding for Biotechnology Research and Development Programs at the Agency for International Development Department of the Interior, Environment, and Related Agencies Appropriations for FY 2009 Funding for the Environmental Protection Agency FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for National Institutes of Health Funding for Bioterrorism and Emergency Preparedness Funding for Pandemic Influenza Preparedness Funding for the Food and Drug Administration (Human Drug, Biologics, Food Safety, Critical Path, Regan-Udall Foundation, Center for Veterinary Medicine) Funding for Biomedical Advanced Research & Development Authority (BARDA) Funding for USDA/APHIS Funding for Biorefinery Construction, Research & Development Department of Homeland Security Appropriations Act for FY 2009 Drug Importation

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
TRICIA BROOKS —
MATT CARR —
PATRICK BRAERTON CARROLL Legislative Assistant, Congressman LaHood
CHRISTOPHER COLWELL —
BRENT ALAN DELMONTE —
SANDRA DENNIS —
AMY EHLERS —
ALAN EISENBERG —
ANDREW EMMETT —
BRENT ERICKSON —
JEANNE HAGGERTY Policy Advisor, Congressman Joe Barton
ELI JOSEPH —
SHELLY MUI-LIPNIK —
DARYL PRITCHARD New —
SARA RADCLIFFE —
JOHN MACK TAYLOR —

Contacted: Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Congressional Budget Office (CBO); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Natl Economic Council (NEC); Commerce, Dept of (DOC); Treasury, Dept of; Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); White House Office; U.S. Agency for International Development (USAID); Office of Management & Budget (OMB); Patent & Trademark Office (PTO); Small Business Administration (SBA); Centers For Disease Control & Prevention (CDC); SENATE; State, Dept of (DOS); Health & Human Services, Dept of (HHS); Securities & Exchange Commission (SEC); Council of Economic Advisers (CEA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2642 (110th), S. 3260 (110th)

Consumer Issues/Safety/Products CSP

Genetically Engineered (GE) Animals U.S. Government Policy Position for Codex Guidelines on Food Safety Risk Assessment for rDNA Animals FDA and USDA Draft Regulation of GE Animals H. R. 6432 Drug Safety Implementation of Food & Drug Administration Amendments Act of 2007 Clinical Trial Registry and Results Databases Risk Management Plans Heparin Contamination Counterfeit Drugs H.R. 5839: Safeguarding America's Pharmaceuticals Act of 2008 FDA Globalization Act of 2008 H.R. 3610: The Food and Drug Import Safety Act of 2007 Drug Importation Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009 (S.3181) Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Adventitious Presence (Low Level Presence) U.S. Government Policy Position for Codex Guidelines on Adventitious Presence Korea Trade Negotiations EU Trade Meetings Physician Payments Sunshine Act S.2029 Livestock Cloning/Product Labeling FDA Risk Assessment on Cloning USDA Marketing and Regulatory Programs, Cloning Transition Period USDA Economic Report on Impact of Cloning on US Agriculture and Food Production USDA National Organic Program, Advance Notice of Proposed Rulemaking Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 H.R. 3161 S. 1859 H.R. 992 S. 414 H.R. 1396 S. 536 H.R. 4855 H.R. 2419 S.2663 Access to Drug Pricing Data H.R. 5683 Funding for Food Safety at the Food and Drug Administration Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642)

LobbyistCovered position, as disclosed
SUSIE AHN —
SHARON BOMER LAURITSEN —
MELISSA BOWIE Chief Health Counsel, U.S. Senate HELP Subcommittee
PATRICK BRAERTON CARROLL Legislative Assistant, Congressman LaHood
BRENT ALAN DELMONTE —
SANDRA DENNIS —
TOM DILENGE —
ANDREW EMMETT —
BARBARA GLENN —
JEANNE HAGGERTY Policy Advisor, Congressman Joe Barton
ELI JOSEPH —
KATHERINE MCCARTHY —
BILL A OLSON Legislative Assistant, Rep. John Shimkus
SARA RADCLIFFE —
JOHN MACK TAYLOR —

Contacted: Treasury, Dept of; Office of Management & Budget (OMB); Natl Economic Council (NEC); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Council of Economic Advisers (CEA); Natl Institutes of Health (NIH); White House Office; U.S. Trade Representative (USTR); Small Business Administration (SBA); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); SENATE; Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); U.S. Agency for International Development (USAID); Commerce, Dept of (DOC); Office of Science & Technology Policy (OSTP); Congressional Budget Office (CBO)

Bills named: S. 536 (110th), H.R. 3610 (110th), S. 414 (110th), H.R. 992 (110th), H.R. 3161 (110th), H.R. 2419 (110th), S. 1859 (110th), H.R. 2642 (110th), S. 3181 (110th), H.R. 1396 (110th), H.R. 4855 (110th), S. 2029 (110th), H.R. 5839 (110th), H.R. 6432 (110th), S. 2663 (110th), H.R. 5683 (110th)

Government Issues GOV

False Claims Act Amendment S.2041 FDA Debarment H.R. 6378: The Strengthening of FDA Integrity Act Access to Drug Pricing Data H.R. 5683

LobbyistCovered position, as disclosed
MELISSA BOWIE Chief Health Counsel, Senate, HELP, Subcommittee
BRENT ALAN DELMONTE —
SANDRA DENNIS —
TOM DILENGE —
JEANNE HAGGERTY Policy Advisor, Congressman Joe Barton
ELI JOSEPH —

Contacted: Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Securities & Exchange Commission (SEC); Congressional Budget Office (CBO); Small Business Administration (SBA); White House Office; Health & Human Services, Dept of (HHS); Treasury, Dept of; Natl Institutes of Health (NIH); U.S. Agency for International Development (USAID); Commerce, Dept of (DOC); Food & Drug Administration (FDA); Office of Management & Budget (OMB); SENATE; Council of Economic Advisers (CEA); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); U.S. Trade Representative (USTR); Natl Economic Council (NEC); Patent & Trademark Office (PTO)

Bills named: S. 2041 (110th), H.R. 6378 (110th), H.R. 5683 (110th)

Energy/Nuclear ENG

Biofuels Tax Credit H.R. 2419/H.R. 6124 Biorefinery Construction, Research & Development Appropriations FY 2008 Supplemental Appropriations Bill (H.R. 2642) Biorefinery Loan Program H.R. 6124 Biofuels Emission Audits S. 3036: Lieberman-Warner Climate Security Act of 2008 Farm Legislation H.R. 2419/H.R. 6124 Biofuels Tax Credit Funding for Biofuels Energy and Water Development and Related Agencies Appropriations Act for FY 2009

LobbyistCovered position, as disclosed
MATT CARR —
PATRICK BRAERTON CARROLL Legislative Assistant, Congressman LaHood
BRENT ALAN DELMONTE —
AMY EHLERS —
BRENT ERICKSON —
ELI JOSEPH —
BILL A OLSON Legislative Assistant, Rep. John Shimkus
PAUL POTEET —

Contacted: Council of Economic Advisers (CEA); Small Business Administration (SBA); SENATE; State, Dept of (DOS); Agriculture, Dept of (USDA); Natl Economic Council (NEC); Centers For Disease Control & Prevention (CDC); Office of Science & Technology Policy (OSTP); Securities & Exchange Commission (SEC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); U.S. Agency for International Development (USAID); Environmental Protection Agency (EPA); Congressional Budget Office (CBO); Commerce, Dept of (DOC); Treasury, Dept of; Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); White House Office; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Food & Drug Administration (FDA)

Bills named: H.R. 6124 (110th), S. 3036 (110th), H.R. 2642 (110th), H.R. 2419 (110th)

Animals ANI

Genetically Engineered (GE) Animals U.S. Government Policy Position for Codex Guidelines on Food Safety Risk Assessment for rDNA Animals FDA and USDA Draft Regulation of GE Animals H. R. 6432 Livestock Cloning/Product Labeling FDA Risk Assessment on Cloning USDA Marketing and Regulatory Programs, Cloning Transition Period USDA Economic Report on Impact of Cloning on US Agriculture and Food Production USDA National Organic Program, Advance Notice of Proposed Rulemaking Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 H.R. 3161 S. 1859 H.R. 992 S. 414 H.R. 1396 S. 536 H.R. 4855 H.R. 2419 S.2663

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
MELISSA BOWIE Chief Health Counsel, Senate HELP, Subcommittee
PATRICK BRAERTON CARROLL Legislative Assistant, Congressman LaHood
BRENT ALAN DELMONTE —
BARBARA GLENN —
JEANNE HAGGERTY Policy Advisor, Congressman Joe Barton
ELI JOSEPH —
BILL A OLSON Legislative Assistant, Rep. John Shimkus

Contacted: Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); Natl Economic Council (NEC); White House Office; State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Office of Science & Technology Policy (OSTP); Centers For Disease Control & Prevention (CDC); Congressional Budget Office (CBO); Agriculture, Dept of (USDA); Council of Economic Advisers (CEA); Treasury, Dept of; Securities & Exchange Commission (SEC); SENATE; U.S. Agency for International Development (USAID); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Small Business Administration (SBA)

Bills named: H.R. 3161 (110th), H.R. 992 (110th), S. 2663 (110th), H.R. 4855 (110th), H.R. 6432 (110th), S. 1859 (110th), S. 414 (110th), H.R. 1396 (110th), S. 536 (110th), H.R. 2419 (110th)

Pharmacy PHA

Comparative Effectiveness Program Initiatives H.R. 6331 S. 3101 Medicare/Medicaid Packages Medicaid Rebates H.R. 1424 H.R. 6331 H.R. 3162 H.R. 1367 S.3101 Medicaid/Medicare Packages Dual Proportionality Medicaid Rebates in Hospital Outpatient Setting CMS AMP Regulations Access to Drug Pricing Data H.R. 5683 Influenza Vaccine Supply and Immunization Recommendations Outpatient Prospective Payment Service S. 3101: Medicare Improvements for Patients and Providers Act of 2008 Drug Importation Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009 (S.3181) Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Drug Safety Implementation of Food & Drug Administration Amendments Act of 2007 Clinical Trial Registry and Results Databases Risk Management Plans Heparin Contamination Counterfeit Drugs H.R. 5839: Safeguarding America's Pharmaceuticals Act of 2008 FDA Globalization Act of 2008 H.R. 3610: The Food and Drug Import Safety Act of 2007

LobbyistCovered position, as disclosed
SUSIE AHN —
MELISSA BOWIE Chief Health Counsel, Senate HELP, Subcommittee
TRICIA BROOKS —
PATRICK BRAERTON CARROLL Legislative Assistant, Congressman LaHood
CHRISTOPHER COLWELL —
BRENT ALAN DELMONTE —
SANDRA DENNIS —
TOM DILENGE —
JEANNE HAGGERTY Policy Advisor, Congressman Joe Barton
ELI JOSEPH —
KATHERINE MCCARTHY —
SARA RADCLIFFE —
JOHN SIRACUSA —
JOHN MACK TAYLOR —

Contacted: Office of Management & Budget (OMB); SENATE; Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Small Business Administration (SBA); White House Office; U.S. Agency for International Development (USAID); Treasury, Dept of; Patent & Trademark Office (PTO); Congressional Budget Office (CBO); Securities & Exchange Commission (SEC); Council of Economic Advisers (CEA); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Agriculture, Dept of (USDA); Centers For Disease Control & Prevention (CDC); Office of Science & Technology Policy (OSTP)

Bills named: H.R. 1367 (110th), H.R. 3162 (110th), H.R. 6331 (110th), S. 3101 (110th), H.R. 1424 (110th), H.R. 5839 (110th), S. 3181 (110th), H.R. 3610 (110th), H.R. 5683 (110th)

Fuel/Gas/Oil FUE

Biofuels Tax Credit H.R. 2419/H.R. 6124 Renewable Fuels Standard Biorefinery Construction, Research & Development Appropriations H.R. 2642 Biorefinery Loan Program H.R. 6124 Funding for Biofuels Energy and Water Development and Related Agencies Appropriations Act for FY 2009 Farm Legislation H.R. 2419/H.R. 6124 Biofuels Tax Credit

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
MATT CARR —
PATRICK BRAERTON CARROLL Legislative Assistant, Congressman LaHood
BRENT ALAN DELMONTE —
AMY EHLERS —
BRENT ERICKSON —
ELI JOSEPH —
BILL A OLSON Legislative Assistant, Rep. John Shimkus
PAUL POTEET —

Contacted: Food & Drug Administration (FDA); U.S. Agency for International Development (USAID); SENATE; Office of Science & Technology Policy (OSTP); Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); State, Dept of (DOS); Treasury, Dept of; Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); White House Office; Natl Institutes of Health (NIH); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); Council of Economic Advisers (CEA); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Centers For Disease Control & Prevention (CDC); Small Business Administration (SBA)

Bills named: H.R. 6124 (110th), H.R. 2642 (110th), H.R. 2419 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.